Smart health tech company Alcidion has acquired a UK patient flow software company called ExtraMed.
ExtraMed provides patient flow software to NHS trusts and Alcidion’s capture is set to lead to an ‘enhanced offering’ for hospitals and primary and social care organisations.
It’s reported that it will be ‘business as usual’ for both companies at the moment but new opportunities around integration, automation, clinical decision support, resource management, patient observation and clinical communication, are also expected.
Currently, ExtraMed specialises in providing NHS trusts with software that helps frontline staff make informed decisions based on ‘real-time visibility of patient flow’ – working with nine NHS customers in total, including a 10-year Digital Control Centre project and partnership at Salford Royal NHS Foundation Trust, which is part of the Northern Care Alliance NHS Group.
Lynette Ousby, UK General Manager for Alcidion, said: “Bringing ExtraMed and its team of experts in patient flow into the Alcidion Group is a fantastic opportunity to further enhance how we work with hospitals across the UK. The combination of our capabilities and our expanding partner network opens up exciting possibilities as we continue to grow our offering to help NHS hospitals and integrated care systems that want to advance digital maturity by complementing and orchestrating their existing systems.
“Existing ExtraMed customers will benefit from the knowledge and experience we have in developing and delivering technological systems that improve patient care, while current Alcidion customers may take advantage of the digital expertise ExtraMed has in patient flow, in ensuring that each patient gets to the right bed at the right time.”
Susan Say, Managing Director of ExtraMed, added: “All of our customers will continue to receive the same high standard of service as our team joins the wider Alcidion family. The Alcidion Group is a perfect fit for ExtraMed, as we join a clinically driven organisation with a strong history grounded in patient safety and digital innovation.”
Alcidion will purchase 100% of the shares in ExtraMed and all staff, customers and assets are included in the deal.
Kate Quirke, Managing Director of the Alcidion Group, commented: “In combining our customer bases and the established solutions alongside Miya Precision, we are creating a strong competitive advantage and the opportunity for further growth as we look to introduce our Miya product range to these new customers.”
